Xtant Medical Holdings, Inc.

XTNTAMEXUSD
0.32 USD
0.01 (1.80%)🟢LIVE (AS OF 12:42 PM EDT)
🟢Market: OPEN

Xtant Medical Holdings, Inc. (XTNT) trades at $0.32 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Strong Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest XTNT is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Aug 24, 2026.

Open?$0.32
High?$0.32
Low?$0.31
Prev. Close?$0.32
Volume?32.8K
Avg. Volume?216.1K
VWAP?$0.32
Rel. Volume?0.15x
Bid / Ask
Bid?$0.31 × 100
Ask?$0.32 × 500
Spread?$0.01
Midpoint?$0.32
Valuation & Ratios
Market Cap?44.9M
Shares Out?140.3M
Float?48.4M
Float %?34.5%
P/E Ratio?N/A
P/B Ratio?1.12
EPS?-$0.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Employees
151
Market Cap
45.3M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2007-01-31
Address
664 CRUISER LANE
BELGRADE, MT 59714
Phone: 406-388-0480
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
3
Short Sent.?
54
Piotroski F-Score?2/9Weak
Altman Z-Score?-2.55Distress
Confidence?56%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.18%Low
Short Interest?89.0K
Days to Cover?1.7
Free Float48.4M
Avg Daily Volume52.0K
Settlement Date2026-07-31
Financial Health
Current Ratio?2.16Strong
Quick Ratio?1.05Adequate
Cash Ratio?0.33Low
Debt/Equity?0.58Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
94
1.12CHEAP
P/S?
Peers
100
S&P
97
0.41CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-39.4CHEAP
EV/Sales?
Peers
100
S&P
97
0.53CHEAP
Returns & Efficiency
ROE?
S&P
6
-27.8%WEAK
ROA?
S&P
3
-14.0%WEAK
Cash Flow & Enterprise
FCF?$-696000
Enterprise Value?$58.0M
Fundamentals ratios updated end of day